{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:10:54Z","timestamp":1790683854759,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"vor","delay-in-days":220,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.rmcr.2026.102479","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:39:51Z","timestamp":1786405191000},"page":"102479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Sequential autoimmune and neoplastic manifestations during long-term benralizumab therapy for severe eosinophilic asthma: A descriptive case report"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5702-6568","authenticated-orcid":false,"given":"Ayumi","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsunori","family":"Hino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Takeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Seike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.rmcr.2026.102479_bib1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/17476348.2020.1739526","article-title":"Benralizumab: an updated treatment of eosinophilic asthma","volume":"14","author":"Cushen","year":"2020","journal-title":"Expert Rev. Respir. Med."},{"issue":"12","key":"10.1016\/j.rmcr.2026.102479_bib2","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/s41577-024-01048-y","article-title":"Spatial adaptation of eosinophils and their emerging roles in homeostasis, infection and disease","volume":"24","author":"Arnold","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.rmcr.2026.102479_bib3","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1393134","article-title":"Eosinophils: the unsung heroes in cancer?","volume":"7","author":"Varricchi","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.rmcr.2026.102479_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103333","article-title":"Synovial regulatory T cells expressing ST2 deteriorate joint inflammation through the suppression of immunoregulatory eosinophils","volume":"149","author":"Hattori","year":"2024","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.rmcr.2026.102479_bib5","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.2147\/JAA.S342993","article-title":"Development of rheumatoid arthritis during Anti-Interleukin-5 therapy in a patient with refractory chronic Eosinophilic Pneumonia","volume":"14","author":"Kawabata","year":"2021","journal-title":"J. Asthma Allergy"},{"issue":"4","key":"10.1016\/j.rmcr.2026.102479_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003583","article-title":"Anti-IL-5 biologics and rheumatoid arthritis: a single-centre 500 patient year exposure analysis","volume":"9","author":"Dean","year":"2023","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.rmcr.2026.102479_bib7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/1097-0142(19830701)52:1<126::AID-CNCR2820520123>3.0.CO;2-Y","article-title":"Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer","volume":"52","author":"Ownby","year":"1983","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.rmcr.2026.102479_bib8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40264-020-00926-3","article-title":"Safety of eosinophil-depleting therapy for severe, eosinophilic asthma: focus on benralizumab","volume":"43","author":"Jackson","year":"2020","journal-title":"Drug Saf."},{"issue":"12","key":"10.1016\/j.rmcr.2026.102479_bib9","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1016\/j.jaip.2021.07.058","article-title":"Integrated safety and efficacy among patients receiving benralizumab for up to 5 years","volume":"9","author":"Korn","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007126001164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007126001164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:34:52Z","timestamp":1789472092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007126001164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":9,"alternative-id":["S2213007126001164"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2026.102479","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sequential autoimmune and neoplastic manifestations during long-term benralizumab therapy for severe eosinophilic asthma: A descriptive case report","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2026.102479","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102479"}}